Voyager Therapeutics (VYGR) Assets Average (2016 - 2025)
Historic Assets Average for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to $305.2 million.
- Voyager Therapeutics' Assets Average fell 2920.84% to $305.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $305.2 million, marking a year-over-year decrease of 2920.84%. This contributed to the annual value of $372.2 million for FY2024, which is 4576.52% up from last year.
- As of Q3 2025, Voyager Therapeutics' Assets Average stood at $305.2 million, which was down 2920.84% from $337.7 million recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Assets Average registered a high of $452.9 million during Q2 2024, and its lowest value of $170.9 million during Q4 2022.
- Its 5-year average for Assets Average is $292.2 million, with a median of $305.1 million in 2023.
- As far as peak fluctuations go, Voyager Therapeutics' Assets Average crashed by 3062.54% in 2021, and later skyrocketed by 8896.02% in 2023.
- Voyager Therapeutics' Assets Average (Quarter) stood at $189.3 million in 2021, then decreased by 9.72% to $170.9 million in 2022, then soared by 88.96% to $323.0 million in 2023, then grew by 26.81% to $409.5 million in 2024, then fell by 25.48% to $305.2 million in 2025.
- Its Assets Average was $305.2 million in Q3 2025, compared to $337.7 million in Q2 2025 and $373.1 million in Q1 2025.